Increasing Preference for Monoclonal Antibodies is Reflecting Positively on UK Cancer Monoclonal Antibodies Market
Published: Nov 2020
UK cancer monoclonal antibodies market is estimated to grow at a CAGR of 8.2% during the forecast period. The rising preference for monoclonal antibodies is leveraging market growth. Monoclonal antibodies act as one of the potential immunotherapies in the country to identify and attach to particular proteins on the cancer cells surface. It works as immunotherapy in several ways as these therapies may trigger the immune system and support the immune system to attack cancer cells.
Increasing Funding for Cancer Research is Offering an Opportunity for North American Cancer Monoclonal Antibodies Market
Published: Nov 2020
North American cancer monoclonal antibodies market is estimated to grow at a CAGR of 9.6% during the forecast period. Significant availability of funding for cancer research is providing scope for market growth. For instance, the FY 2020 Department of Health and Human Services Appropriations Act and the 21st Century Cures Act distributed $6.4 billion to National Cancer Institute (NCI), a $297 million net growth over the FY 2019.
Increasing Awareness Regarding Cancer is Driving Indian Cancer Monoclonal Antibodies Market
Published: Nov 2020
Indian cancer monoclonal antibodies market is estimated to grow at a CAGR of 12.5% during the forecast period. Rising awareness regarding cancer is primarily encouraging market growth. Indian government programs to raise public awareness regarding cancer have been witnessed which is offering an opportunity for market growth.
Increasing Launches of Monoclonal Antibodies Biosimilars is Reflecting Positively on European Cancer Monoclonal Antibodies Market
Published: Nov 2020
European cancer monoclonal antibodies market is estimated to grow at a CAGR of 8.0% during the forecast period. Increasing launches of monoclonal antibodies biosimilars is offering an opportunity for market growth. For instance, in April 2020, Pfizer Inc. declared the European Commission approval of RUXIENCE (rituximab).
Rising Awareness Regarding Cancer is Driving the Asia-Pacific Cancer Monoclonal Antibodies Market
Published: Nov 2020
Asia-Pacific cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.2% during the forecast period. Increasing awareness regarding cancer is one of the pivotal factors accelerating market growth. Biopharmaceutical firms have reported the launch of public awareness campaigns for cancer.
Increasing Launches of Biosimilars to Drive China Cancer Monoclonal Antibodies Market
Published: Nov 2020
China cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.6% during the forecast period. An increasing launch of biosimilars has been witnessed in the country owing to the increasing focus on providing affordable cancer therapy in the country. For instance, in August 2020, China’s NMPA (National Medical Products Administration) approved a biosimilar version of Roche’s Herceptin (trastuzumab), Shanghai’s Henlius which is referred to as HLX02 to treat HER2-mutated cancers.
Increasing Research on Monoclonal Antibodies is Offering Opportunity for the Global Cancer Monoclonal Antibodies Market
Published: Nov 2020
The global cancer monoclonal antibodies market is estimated to grow at a CAGR of 9.8% during the forecast period. Significant research on monoclonal antibodies have been witnessed, which is providing a scope for the market growth. The availability of funding and the increasing focus of researchers and biopharmaceutical firms towards the development of monoclonal antibodies are some major factors driving the research on monoclonal antibodies.
Rising Clinical Trials to Offer an Opportunity for the Global Metabolic Disorder Therapeutics Market
Published: Nov 2020
The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. An increasing number of clinical trials have been witnessed over the years owing to the rising prevalence of metabolic disorders and increasing demand for more effective treatment.
Rising Demand from End-Use Industries to Reflect Positively on the Global Molded Pulp Packaging Market
Published: Nov 2020
The global molded pulp packaging market is estimated to grow at a CAGR of 4.6% during the forecast period. The increasing demand for molded pulp fiber packaging across end-use industries such as food packaging, food service, and electronics sector is supporting accelerating market growth.
Emerging Demand for Sustainable Packaging is Driving European Molded Pulp Packaging Market
Published: Nov 2020
European molded pulp packaging market is estimated to grow at a CAGR of 3.7% during the forecast period. Emerging demand for sustainable packaging is accelerating the adoption of molded pulp packaging in the region.